Efficacy and Safety of Modified Dual Therapy as the First-line Regimen for the Treatment of Helicobacter pylori Infection: A Meta-Analysis of Randomized Controlled Trials.

Authors:
Huang Q; Shi Z; Cheng H; Ye H; Zhang X.

Journal:
J Clin Gastroenterol

Publication Year: 2021

DOI:
10.1097/MCG.0000000000001448

PMCID:
PMC8513521

PMID:
33074949

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Clin Gastroenterol

Abbreviation: J Clin Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Early Predictive Value of Different Indicators for Persistent Organ Failure in Acute Pancreatitis: …
Wang H; Lü M; Li W and 2 more (2024) - Transparency Score: 2/6
Management of Gastrointestinal Symptoms in Parkinson's Disease: A Comprehensive Review of Clinical …
Pasricha TS; Guerrero-Lopez IL; Kuo B. (2024) - Transparency Score: 3/6
Differential Diagnosis of Chronic Diarrhea: An Algorithm to Distinguish Irritable Bowel Syndrome Wi…
Brenner DM; Domínguez-Muñoz JE. (2023) - Transparency Score: 3/6
Efficacy and Safety of Radiofrequency Ablation Plus Stent Versus Stent-alone Treatments for Maligna…
Khizar H; Hu Y; Wu Y and 4 more (2023) - Transparency Score: 3/6
Health Care Cost Analysis of PPI or P-CAB-First Treatment in Patients With Gastroesophageal Reflux …
Miwa H; Shiotani A; Takeda M and 3 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"Supported by National Natural Science Foundation of China, No. 81973615"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025